• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活动期溃疡性结肠炎患者粪便钙卫蛋白水平日内变异性高:粪便采样的最佳时间是什么?

High within-day variability of fecal calprotectin levels in patients with active ulcerative colitis: what is the best timing for stool sampling?

作者信息

Calafat Margalida, Cabré Eduard, Mañosa Míriam, Lobatón Triana, Marín Laura, Domènech Eugeni

机构信息

*Hospital Universitari Germans Trias i Pujol, Ciberehd, Badalona, Spain; and †Universitat Autònoma de Barcelona, Barcelona, Spain.

出版信息

Inflamm Bowel Dis. 2015 May;21(5):1072-6. doi: 10.1097/MIB.0000000000000349.

DOI:10.1097/MIB.0000000000000349
PMID:25793326
Abstract

BACKGROUND

Fecal calprotectin (FC) is considered the best noninvasive way to assess disease activity in ulcerative colitis (UC). However, it is not known which is the more suitable moment for stool sampling in patients with increased stool frequency. The aims of this study were to assess the intraindividual variation of FC within day and to evaluate if the first bowel movement in the morning is the more suitable sample for FC measurement in patients with acute flares of UC.

PATIENTS AND METHODS

Patients admitted because of active UC were invited to collect samples from several bowel movements (including the first in the morning) during the same day providing their ordinal chronology. FC was measured by means of a quantitative rapid point-of-care test based on lateral flow assay immunochromatography.

RESULTS

Eighteen patients were included for a total of 56 stool samples. Most patients had extensive UC and severe disease activity. Within-day FC values varied widely, and the median coefficient of variation was 40% (5%-114%) with a median range of variation of FC values of 3887 mg/kg (69-9946). The sample from the first stool in the morning obtained the highest individual FC within-day value in 33.3% of cases and the lowest in 38.9%.

CONCLUSIONS

FC values widely vary between motions in patients with active UC. Stool sample collection from the first bowel movement in the morning does not ensure the highest or lowest within-day FC value. In patients with overt active UC, a single FC determination should not be used as the basis for therapeutic strategies.

摘要

背景

粪便钙卫蛋白(FC)被认为是评估溃疡性结肠炎(UC)疾病活动度的最佳非侵入性方法。然而,对于排便次数增加的患者,尚不清楚何时采集粪便样本更为合适。本研究的目的是评估FC在一天内的个体内变异,并评估晨起的第一次排便是否是UC急性发作患者测量FC的更合适样本。

患者与方法

因活动性UC入院的患者被邀请在同一天内从多次排便(包括晨起第一次排便)中采集样本,并提供其顺序时间。FC通过基于侧向流分析免疫层析的定量快速即时检测法进行测量。

结果

纳入18例患者,共采集56份粪便样本。大多数患者患有广泛性UC且疾病活动度严重。一天内FC值变化很大,变异系数中位数为40%(5%-114%),FC值变异中位数范围为3887mg/kg(69-9946)。晨起第一次粪便样本在33.3%的病例中获得一天内个体FC最高值,在38.9%的病例中获得最低值。

结论

活动性UC患者不同排便之间的FC值差异很大。晨起第一次排便采集的粪便样本并不能确保获得一天内FC的最高或最低值。对于明显活动性UC患者,不应将单次FC测定作为治疗策略的依据。

相似文献

1
High within-day variability of fecal calprotectin levels in patients with active ulcerative colitis: what is the best timing for stool sampling?活动期溃疡性结肠炎患者粪便钙卫蛋白水平日内变异性高:粪便采样的最佳时间是什么?
Inflamm Bowel Dis. 2015 May;21(5):1072-6. doi: 10.1097/MIB.0000000000000349.
2
The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis.粪便钙卫蛋白的个体内变异性:活动性溃疡性结肠炎患者的前瞻性研究。
J Crohns Colitis. 2015 Jan;9(1):26-32. doi: 10.1016/j.crohns.2014.06.002.
3
A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis.一种新的快速定量粪便钙卫蛋白检测可预测溃疡性结肠炎的内镜活动度。
Inflamm Bowel Dis. 2013 Apr;19(5):1034-42. doi: 10.1097/MIB.0b013e3182802b6e.
4
Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission.缓解期溃疡性结肠炎患者粪便钙卫蛋白的系列半定量测定
Scand J Gastroenterol. 2018 Feb;53(2):152-157. doi: 10.1080/00365521.2017.1410219. Epub 2017 Nov 30.
5
Within-Stool and Within-Day Sample Variability of Fecal Calprotectin in Patients With Inflammatory Bowel Disease: A Prospective Observational Study.炎症性肠病患者粪便钙卫蛋白的粪便内及日内样本变异性:一项前瞻性观察研究。
J Clin Gastroenterol. 2018 Mar;52(3):235-240. doi: 10.1097/MCG.0000000000000776.
6
Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome.与两项患者报告结局相比,粪便钙卫蛋白对溃疡性结肠炎缓解诱导治疗短期结局的早期预测价值。
PLoS One. 2017 Sep 21;12(9):e0185131. doi: 10.1371/journal.pone.0185131. eCollection 2017.
7
Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.粪便钙卫蛋白可预测溃疡性结肠炎患者的黏膜完全愈合,且与溃疡性结肠炎内镜严重程度指数的相关性优于与梅奥内镜亚评分的相关性。
BMC Gastroenterol. 2017 Oct 23;17(1):110. doi: 10.1186/s12876-017-0669-7.
8
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.粪便钙卫蛋白是炎症性肠病内镜下病变的替代标志物。
Inflamm Bowel Dis. 2012 Dec;18(12):2218-24. doi: 10.1002/ibd.22917. Epub 2012 Feb 16.
9
Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.粪便钙卫蛋白测量可作为炎症性肠病患者短期临床结局和黏膜愈合标志物。
World J Gastroenterol. 2017 Nov 7;23(41):7387-7396. doi: 10.3748/wjg.v23.i41.7387.
10
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.粪便钙卫蛋白和乳铁蛋白用于预测炎症性肠病复发
Inflamm Bowel Dis. 2009 Aug;15(8):1190-8. doi: 10.1002/ibd.20933.

引用本文的文献

1
Fecal Calprotectin as a Biomarker of Crohn's Disease in Patients With Short Disease Durations: A Prospective, Single-Center, Cross-Sectional Study.粪便钙卫蛋白作为疾病病程短的克罗恩病患者的生物标志物:一项前瞻性、单中心横断面研究
Gastroenterol Res Pract. 2025 Apr 25;2025:9984055. doi: 10.1155/grp/9984055. eCollection 2025.
2
Changes of leucine-rich alpha 2 glycoprotein could be a marker of changes of endoscopic and histologic activity of ulcerative colitis.富含亮氨酸的α2糖蛋白的变化可能是溃疡性结肠炎内镜及组织学活动变化的一个标志物。
Sci Rep. 2025 Feb 12;15(1):5248. doi: 10.1038/s41598-025-89615-8.
3
Fecal calprotectin in pediatric gastrointestinal diseases: Pros and cons.
粪便钙卫蛋白在儿童胃肠道疾病中的利弊
World J Clin Pediatr. 2024 Jun 9;13(2):93341. doi: 10.5409/wjcp.v13.i2.93341.
4
Validation of rapid fecal calprotectin assay using particle enhanced turbidimetric immunoassay for inflammatory bowel disease.基于胶乳增强免疫比浊法的快速粪便钙卫蛋白检测在炎症性肠病中的验证。
Sci Rep. 2024 Jan 18;14(1):1653. doi: 10.1038/s41598-024-51580-z.
5
Fecal calprotectin level is nonlinearly associated with GI pathogen detection in patients with and without inflammatory bowel disease.粪便钙卫蛋白水平与炎症性肠病患者和非炎症性肠病患者的胃肠道病原体检测呈非线性相关。
J Clin Microbiol. 2023 Dec 19;61(12):e0094623. doi: 10.1128/jcm.00946-23. Epub 2023 Dec 1.
6
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis.憩室炎和并发症评估分类、CODA 评分和粪便钙卫蛋白在憩室病患者临床评估中的应用:决策曲线分析。
United European Gastroenterol J. 2023 Sep;11(7):642-653. doi: 10.1002/ueg2.12369. Epub 2023 Aug 7.
7
Biological markers of disease activity in inflammatory bowel diseases.炎症性肠病疾病活动的生物标志物
Prz Gastroenterol. 2023;18(2):141-147. doi: 10.5114/pg.2023.129412. Epub 2023 Jul 27.
8
Fecal Biomarkers of Neutrophil and Eosinophil Origin Reflect the Response to Biological Therapy and Corticosteroids in Patients With Inflammatory Bowel Disease.粪便中中性粒细胞和嗜酸性粒细胞来源的生物标志物反映了炎症性肠病患者对生物治疗和皮质类固醇的反应。
Clin Transl Gastroenterol. 2023 Aug 1;14(8):e00605. doi: 10.14309/ctg.0000000000000605.
9
Association of Fecal Calprotectin With Endoscopic and Histologic Activity in Pediatric Inflammatory Bowel Disease.粪便钙卫蛋白与小儿炎症性肠病内镜及组织学活动的相关性
JPGN Rep. 2021 Oct 13;2(4):e129. doi: 10.1097/PG9.0000000000000129. eCollection 2021 Nov.
10
Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease.B细胞活化因子(BAFF)在炎症性肠病中的作用。
Diagnostics (Basel). 2021 Dec 27;12(1):45. doi: 10.3390/diagnostics12010045.